Company intelligence / Profile preview

Verpond

Ownership: Private
Development stage: Preclinical

Overview

Verpond is developing large-scale biomass generation and conversion processes to produce cost-competitive biofuels and biobased products from algal biomass. The company’s OAACS™ system aims to enable scalable algal cultivation for use in fuels, fertilizers, animal feeds, aquaculture feeds, food ingredients, carbon capture/sequestration applications, and more. No clinical results as it is not a healthcare or pharmaceutical entity.

Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Verpond.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Verpond.

Explore the full profile